Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 528 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 8 | 8 | 10 | 14 | 9 | 3 | 3 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 663 |
| Views | |
|---|---|
| United States | 107 |
| Argentina | 95 |
| Canada | 44 |
| Peru | 35 |
| Mexico | 25 |
| Spain | 19 |
| Colombia | 14 |
| Chile | 12 |
| China | 12 |
| Ecuador | 12 |
| Views | |
|---|---|
| Ottawa | 36 |
| Buenos Aires | 27 |
| Lima | 20 |
| Mexico | 11 |
| Federal | 9 |
| Houston | 8 |
| Quito | 8 |
| Menlo Park | 7 |
| San Diego | 7 |
| Vancouver | 7 |